| Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118) |
|---|
| 06/02/2004 | CN1152014C N-aryl anthranilic acid derivatives and uses thereof |
| 06/02/2004 | CN1151836C Compounds and compositions for delivering active agents |
| 06/01/2004 | US6743781 Glycerolipid compounds useful for the transfer of an active substance into a target cell |
| 05/27/2004 | US20040102650 Reacting hexachloroacetone with solvent-suspended resin-bound triphenylphosphine, chlorinating retinoic acid to provide retinoyl chloride, then stirring in pyridine; chromatography; for induction of apoptosis in cancer cells |
| 05/27/2004 | US20040102513 2'-Substituted 1,1'-biphenyl-2-carboxamides, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them |
| 05/27/2004 | US20040102490 Antilipemic agents, antidiabetic agents and treatment of obesity |
| 05/27/2004 | US20040101864 Chemical process |
| 05/27/2004 | US20040101523 Blocking biosynthesis of neurotransmitters; enzyme inhibitors; cardiovascular disorders |
| 05/27/2004 | US20040101446 Arrays and artificial receptors |
| 05/26/2004 | EP1421060A1 Antiviral protease inhibitors |
| 05/26/2004 | EP1303478B1 Process for the preparation of substituted octanoyl amides |
| 05/26/2004 | EP1015418B1 Denatonium capsaicinate and methods of producing the same |
| 05/26/2004 | EP1005445B1 N-alkanoylphenylalanine derivatives |
| 05/26/2004 | CN1151133C Anthranilic acid amides and use thereof as medicaments |
| 05/25/2004 | US6740682 Treatment of thrombotic diseases, asthma, emphysema, cirrhosis, arthritis, carcinoma, melanoma, restenois, atheroma, trauma, shock and reperfusion injury. |
| 05/25/2004 | US6740673 Quarternary ammonium compounds |
| 05/25/2004 | US6740371 Excellent in uniformity; dodecyl (3,5-bis(4-amino benzoylamino)) benzoate |
| 05/21/2004 | WO2004041161A2 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity |
| 05/21/2004 | WO2002074719A3 Inhibitors of plasmepsins |
| 05/21/2004 | CA2502174A1 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity |
| 05/20/2004 | US20040097589 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 05/20/2004 | US20040097585 4-(2,6-difluorophenyl)-4-oxobutyric acid and derivatives; milder side effects; insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis, arteriosclerosis |
| 05/20/2004 | US20040097547 For therapy of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer |
| 05/20/2004 | US20040097522 For controlling undesirable microorganisms and animal pests |
| 05/20/2004 | US20040097407 Method for the synthesis of compounds of formula I and their uses thereof |
| 05/20/2004 | US20040096976 Block immobilized om a support; coupling; biosynthesis |
| 05/20/2004 | US20040096908 Methods of using arrays and artificial receptors |
| 05/19/2004 | EP1420011A1 Compounds usefulfor treating allergic and inflammatory diseases |
| 05/19/2004 | EP1420010A1 Amphoteric lipid compound and use thereof |
| 05/19/2004 | EP1420009A2 Novel amino acid derivatives with improved multi-drug resistance activity |
| 05/19/2004 | EP1216095B1 Method for activating passivated iron |
| 05/19/2004 | DE10250743A1 Neue Amid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New amide compounds with MCH-antagonistic activity and pharmaceutical compositions containing them |
| 05/19/2004 | CN1498205A Aryl and biaryl compounds having MCH modulatory activity |
| 05/18/2004 | US6737420 Compounds to treat Alzheimer's disease |
| 05/13/2004 | WO2004039764A1 Novel amide compounds with mch antagonistic effect and medicaments comprising said compounds |
| 05/13/2004 | WO2004039320A2 STEREOISOMERS OF p-HYDROXY-MILNACIPRAN, AND METHODS OF USE THEREOF |
| 05/13/2004 | WO2003006652A3 Inhibition of specific histone deacetylase isoforms |
| 05/13/2004 | US20040092598 Antiproliferative agnets; anticancer agents; skin disorders |
| 05/13/2004 | US20040092576 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 05/13/2004 | US20040092553 Excitatory amino acid receptor modulators |
| 05/13/2004 | US20040092518 Compounds for the treatment of metabolic disorders |
| 05/13/2004 | US20040092517 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours |
| 05/13/2004 | US20040092516 Insulin resistance; antidiabetic agents; antilipemic agents; anticholesterol agents; cardiovascular disorders |
| 05/13/2004 | US20040092505 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone |
| 05/13/2004 | US20040092490 Substituted tetracycline compounds for the treatment of malaria |
| 05/13/2004 | US20040091426 Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes |
| 05/13/2004 | CA2503381A1 Stereoisomers of p-hydroxy-milnacipran, and methods of use thereof |
| 05/12/2004 | EP1367046A9 Disubstituted lavendustin A analogs and pharmaceutical compositions comprising the analogs |
| 05/12/2004 | EP1163208B1 Caspase inhibitors and uses thereof |
| 05/12/2004 | CN1495157A Preparation method of cyanophthaofluoroaniline |
| 05/12/2004 | CN1149188C Arylaminomethylenecamphor derivatives |
| 05/11/2004 | US6734324 Diketene is reacted with an n-phenyl-p-phenylenediamine in the presence of 3-40% acetic acid and at temperatures of 20 to 100 degrees c; fuel additives, polymer drying accelerators |
| 05/11/2004 | US6734203 Fused imidazolium derivatives |
| 05/06/2004 | WO2004037769A2 Cycloalkylamides and their therapeutic use as antiepileptic and anticonvulsant |
| 05/06/2004 | WO2004037751A2 Aryl and heteroaryl propene amides, derivatives thereof and therapeutic uses thereof |
| 05/06/2004 | WO2004037241A1 Fused cycloalkyl amides and acids and their therapeutic applications for the treatment of i.a. epilepsy |
| 05/06/2004 | WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/06/2004 | WO2003005971A8 Tetracycline compounds having target therapeutic activities |
| 05/06/2004 | US20040087646 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 05/06/2004 | US20040087632 Controlling metabolism of lipids, cholesterol |
| 05/06/2004 | US20040087590 Novel biphenyl and biphenyl-like cannabinoids |
| 05/06/2004 | EP1414809A1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 05/06/2004 | EP1414783A1 Method for the production of amines by reductive amination of carbonyl compounds under transfer-hydrogenation conditions |
| 05/06/2004 | EP1414438A1 Antineoplastic combinations |
| 05/06/2004 | CA2502323A1 Cycloalkylamides and their therapeutic use as antiepileptic and anticonvulsant |
| 05/06/2004 | CA2502320A1 Fused cycloalkyl amides and acids and their therapeutic applications for the treatment of i.a. epilepsy |
| 05/06/2004 | CA2497060A1 Aryl and heteroaryl propene amides, derivatives thereof and therapeutic uses thereof |
| 05/05/2004 | CN1494532A New asymmetric process for preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates |
| 05/05/2004 | CN1494527A Or tho-substituted and meta-substituted bis-aryl compounds, method for production thereof, their use as medicament, and pharmaceutical preparations containing there compounds |
| 05/05/2004 | CN1494425A Carboxamide derivatives as therapeutic agents |
| 05/05/2004 | CN1148360C Intermediate for preparing cascade polymeric ligand usable as contrast medium |
| 05/05/2004 | CN1148344C Process for preparation of 4,4' diaminophenylacyl substituted aniline |
| 05/04/2004 | US6730798 Simultaneous halogenation and hydroxylation under lactonization, azidation, then amination to form 2(s),4(s),5(s),7(s)-2,7-dialkyl-4-hydroxy-5-amino-8-aryl-octanoyl amides |
| 04/29/2004 | WO2004035525A1 Inhibitors of histone deacetylase |
| 04/29/2004 | US20040082812 Using amide of a triiodobenzene compound as chemical intermediate |
| 04/29/2004 | US20040082811 Process for the preparation of n,n-substituted 5-amino-1,3-benzenedicarboxamides |
| 04/29/2004 | US20040082628 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 04/29/2004 | US20040082625 Osteoporosis, bone disorders |
| 04/29/2004 | US20040082569 Novel substituted amides, their preparation and use |
| 04/29/2004 | US20040081620 Measurement anticoagulant |
| 04/29/2004 | US20040081604 Method of separating isotopes |
| 04/29/2004 | CA2501265A1 Inhibitors of histone deacetylase |
| 04/28/2004 | EP1412336A1 Peptoid compounds |
| 04/28/2004 | EP1412324A2 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
| 04/28/2004 | EP1200384B1 2-alkyl-5-halogen-pent-4-ene carboxylic acids and their production |
| 04/28/2004 | CN1147483C Adamantane derivatives |
| 04/27/2004 | US6727250 Administering compounds such as trans-3-(naphth-2-yl)-but-2-enoic acid-n-(2-carboxy-phenyl)-amide or like for therapy of conditions associated with increased telomerase activity, e.g. tumour diseases |
| 04/27/2004 | CA2116867C Novel chelating agent, complex compound of said chelating agent and metallic atom, and diagnostic agent comprising same |
| 04/22/2004 | WO2004033424A1 Watersoluble prodrugs of propofol |
| 04/22/2004 | WO2004033415A1 Nitroaniline-based alkylating agents and their use as prodrugs |
| 04/22/2004 | WO2004033414A1 Mu opioid receptor ligands: methods of use and synthesis |
| 04/22/2004 | WO2004033397A2 Activity-based probes, and methods of their preparation and use |
| 04/22/2004 | WO2003057164A3 Compounds for delivering substances into cells |
| 04/22/2004 | US20040077896 Compounds for the treatment of metabolic disorders |
| 04/22/2004 | US20040077875 (5-(((2,4,6-Trimethylphenyl)amino)carbonyl)-4-methyl-2 -thiazolyl)carbamic Acid, 1,1-dimethylethyl ester for example; treating immunological and oncological disorders such as inflammatory bowel disease or cancer |
| 04/22/2004 | US20040077861 Asymmetric addition of organometallic compounds to chiral sulfinimine to give adducts in predominantly one diastereomer can subsequently be transferred into pure enantiomers of by cleavage of the chiral auxilliary |
| 04/22/2004 | US20040077727 Hydroxamic acid derivative as inhibitor of the formation of soluble human CD23 |
| 04/22/2004 | US20040077693 Integrin receptor inhibitors |
| 04/22/2004 | US20040077628 Melanin-concentrating hormone antagonist |
| 04/22/2004 | US20040077618 Epilepsy, bipolar disorder, psychiatric disorders, migraine, pain, neuroprotection, movement disorders; 2-methylcyclohexanecarboxamide, or 1,1':1',1''-ter(cyclopropane)-2'-carboxamide, or (cis)(2S)-2-((((3R,5S)-3,5-dimethylcyclohexyl) carbonyl)amino)propanoic acid for example |